PTPN11 and neoplasm: Importantly, we identify altered local and systemic diurnal immune perturbations in animals with PNF and find that the immunomodulatory effects of SHP2 inhibition and tumor shrinkage depend on the timing of drug delivery and correlate with immune cell abundance within tumors.